Search Orphan Drug Designations and Approvals
-
Generic Name: | N-[(1S)-1-(4- fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N'-(pyrazin-2-yl)pyridine-2,6- diamine maleate |
---|---|
Date Designated: | 12/07/2022 |
Orphan Designation: | Treatment of myelofibrosis |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
NS Pharma, Inc. 140 East Ridgewood Avenue Suite 280S Paramus, New Jersey 07652 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-